588 related articles for article (PubMed ID: 28173773)
1. Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design.
Rigter LS; Spaander MC; Moons LM; Bisseling TM; Aleman BM; de Boer JP; Lugtenburg PJ; Janus CP; Petersen EJ; Roesink JM; Raemaekers JM; van der Maazen RW; Cats A; Bleiker EM; Snaebjornsson P; Carvalho B; Lansdorp-Vogelaar I; Jóźwiak K; Te Riele H; Meijer GA; van Leeuwen FE; van Leerdam ME
BMC Cancer; 2017 Feb; 17(1):112. PubMed ID: 28173773
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy.
Ykema BLM; Gini A; Rigter LS; Spaander MCW; Moons LMG; Bisseling TM; de Boer JP; Verbeek WHM; Lugtenburg PJ; Janus CPM; Petersen EJ; Roesink JM; van der Maazen RWM; ; Aleman BMP; Meijer GA; van Leeuwen FE; Snaebjornsson P; Carvalho B; van Leerdam ME; Lansdorp-Vogelaar I
Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2157-2168. PubMed ID: 36166472
[TBL] [Abstract][Full Text] [Related]
3. Molecular stool testing as an alternative for surveillance colonoscopy: a cross-sectional cohort study.
van Lanschot MC; Carvalho B; Coupé VM; van Engeland M; Dekker E; Meijer GA
BMC Cancer; 2017 Feb; 17(1):116. PubMed ID: 28173852
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic yield of colonoscopy surveillance in testicular cancer survivors treated with platinum-based chemotherapy: study protocol of a prospective cross-sectional cohort study.
Ykema BLM; Bisseling TM; Spaander MCW; Moons LMG; van der Biessen-van Beek D; Saveur L; Kerst M; Mulder SF; de Wit R; Zweers D; Meijer GA; Beijnen JH; Lansdorp-Vogelaar I; van Leeuwen FE; Snaebjornsson P; van Leerdam ME
BMC Gastroenterol; 2021 Feb; 21(1):67. PubMed ID: 33579196
[TBL] [Abstract][Full Text] [Related]
5. Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.
van Eggermond AM; Schaapveld M; Janus CP; de Boer JP; Krol AD; Zijlstra JM; van der Maazen RW; Kremer LC; van Leerdam ME; Louwman MW; Visser O; De Bruin ML; Aleman BM; van Leeuwen FE
Br J Cancer; 2017 Jul; 117(3):306-314. PubMed ID: 28632726
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors.
Rigter LS; Spaander MCW; Aleman BMP; Bisseling TM; Moons LM; Cats A; Lugtenburg PJ; Janus CPM; Petersen EJ; Roesink JM; van der Maazen RWM; Snaebjornsson P; Kuipers EJ; Bruno MJ; Dekker E; Meijer GA; de Boer JP; van Leeuwen FE; van Leerdam ME
Cancer; 2019 Mar; 125(6):990-999. PubMed ID: 30561773
[TBL] [Abstract][Full Text] [Related]
7. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
[TBL] [Abstract][Full Text] [Related]
8. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
Greuter MJE; de Klerk CM; Meijer GA; Dekker E; Coupé VMH
Ann Intern Med; 2017 Oct; 167(8):544-554. PubMed ID: 28973514
[TBL] [Abstract][Full Text] [Related]
9. High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas: A Cost-Effectiveness Analysis.
Meester RGS; Lansdorp-Vogelaar I; Winawer SJ; Zauber AG; Knudsen AB; Ladabaum U
Ann Intern Med; 2019 Nov; 171(9):612-622. PubMed ID: 31546257
[TBL] [Abstract][Full Text] [Related]
10. Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.
Rigter LS; Snaebjornsson P; Rosenberg EH; Atmodimedjo PN; Aleman BM; Ten Hoeve J; Geurts-Giele WR; ; van Ravesteyn TW; Hoeksel J; Meijer GA; Te Riele H; van Leeuwen FE; Dinjens WN; van Leerdam ME
Gut; 2018 Mar; 67(3):447-455. PubMed ID: 29439113
[TBL] [Abstract][Full Text] [Related]
11. Multitarget Stool RNA Test for Colorectal Cancer Screening.
Barnell EK; Wurtzler EM; La Rocca J; Fitzgerald T; Petrone J; Hao Y; Kang Y; Holmes FL; Lieberman DA
JAMA; 2023 Nov; 330(18):1760-1768. PubMed ID: 37870871
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of alternative colonoscopy surveillance strategies to mitigate metachronous colorectal cancer incidence.
Erenay FS; Alagoz O; Banerjee R; Said A; Cima RR
Cancer; 2016 Aug; 122(16):2560-70. PubMed ID: 27248907
[TBL] [Abstract][Full Text] [Related]
13. Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin Lymphoma.
Geurts YM; Shakir R; Ntentas G; Roberti S; Aznar MC; John KM; Ramroth J; Janus CPM; Krol ADG; Roesink JM; van der Maazen RWM; Zijlstra JM; Darby SC; Aleman BMP; van Leeuwen FE; Cutter DJ; Schaapveld M
JAMA Oncol; 2023 Apr; 9(4):481-489. PubMed ID: 36729438
[TBL] [Abstract][Full Text] [Related]
14. Using a hypothetical scenario to assess public preferences for colorectal surveillance following screening-detected, intermediate-risk adenomas: annual home-based stool test vs. triennial colonoscopy.
Bonello B; Ghanouni A; Bowyer HL; MacRae E; Atkin W; Halloran SP; Wardle J; von Wagner C
BMC Gastroenterol; 2016 Sep; 16(1):113. PubMed ID: 27618798
[TBL] [Abstract][Full Text] [Related]
15. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program.
Chiu SY; Chuang SL; Chen SL; Yen AM; Fann JC; Chang DC; Lee YC; Wu MS; Chou CK; Hsu WF; Chiou ST; Chiu HM
Gut; 2017 Feb; 66(2):293-300. PubMed ID: 26515543
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.
Lansdorp-Vogelaar I; Goede SL; Bosch LJW; Melotte V; Carvalho B; van Engeland M; Meijer GA; de Koning HJ; van Ballegooijen M
Clin Gastroenterol Hepatol; 2018 Apr; 16(4):504-512.e11. PubMed ID: 28733262
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of advanced colorectal neoplasia in the Thai population: a prospective screening colonoscopy of 1,404 cases.
Siripongpreeda B; Mahidol C; Dusitanond N; Sriprayoon T; Muyphuag B; Sricharunrat T; Teerayatanakul N; Chaiwong W; Worasawate W; Sattayarungsee P; Sangthongdee J; Prarom J; Sornsamdang G; Soonklang K; Wittayasak K; Auewarakul CU
BMC Gastroenterol; 2016 Aug; 16(1):101. PubMed ID: 27553627
[TBL] [Abstract][Full Text] [Related]
18. Multi-target stool DNA test in the surveillance of inflammatory bowel disease: a cross-sectional cohort study.
Klepp P; Kisiel JB; Småstuen MC; Røseth A; Andersen SN; Vatn MH; Ahlquist DA; Moum BA; Brackmann S
Scand J Gastroenterol; 2018 Mar; 53(3):273-278. PubMed ID: 29313389
[TBL] [Abstract][Full Text] [Related]
19. Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design.
Dominitz JA; Robertson DJ; Ahnen DJ; Allison JE; Antonelli M; Boardman KD; Ciarleglio M; Del Curto BJ; Huang GD; Imperiale TF; Larson MF; Lieberman D; O'Connor T; O'Leary TJ; Peduzzi P; Provenzale D; Shaukat A; Sultan S; Voorhees A; Wallace R; Guarino PD
Am J Gastroenterol; 2017 Nov; 112(11):1736-1746. PubMed ID: 29016565
[TBL] [Abstract][Full Text] [Related]
20. Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.
Robertson DJ; Lee JK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Lieberman D; Levin TR; Rex DK
Am J Gastroenterol; 2017 Jan; 112(1):37-53. PubMed ID: 27753435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]